[TVTX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
20-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -159.82%
YoY- -36.99%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 45,059 55,868 57,249 50,983 46,687 43,771 42,177 1.10%
PBT -88,528 -65,760 -51,569 -122,093 -30,227 -7,455 -11,038 41.45%
Tax 68 63 4 -471 32 -10,797 6,580 -53.31%
NP -90,173 -65,823 -51,573 -121,622 -30,259 -7,455 -17,618 31.26%
Tax Rate - - - - - - - -
Total Cost 135,232 121,691 108,822 172,605 76,946 51,226 59,795 14.56%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -200.12 -117.82 -90.09 -238.55 -64.81 -17.03 -41.77 29.82%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -1.18 -1.03 -0.84 -2.37 -0.70 -0.18 -0.45 17.42%
EPS Diluted -1.18 -1.03 -0.84 -2.37 -0.69 -0.18 -0.44 17.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.